E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway
Open accessThe DOI matches its Crossref record.
Abstract
Aim:E-cadherin is unusually highly expressed in most ovarian cancers. This study was designed to investigate the roles of E-cadherin in the carcinogenesis and progression of ovarian cancers.Methods:Human ovarian adenocarcinoma cell line SKOV-3 was examined. E-cadherin gene CDH1 in SKOV-3 cells was knocked down via RNA interference (RNAi), and the resultant variation of biological behavior was observed using CCK-8 and colony formation experiment. E-cadherin-mediated Ca2+-dependent cell-cell adhesion was used to study the mechanisms underlying the effects of E-cadherin on the proliferation and survival of SKOV-3 cells. The expression levels of E-cadherin, extracellular signal-related kinase (ERK), phosphorylated ERK (P-ERK) were measured using Western blot assays.Results:Transfection with CDH1-siRNA for 24–96 h significantly suppressed the growth and proliferation of SKOV-3 cells. E-cadherin-mediated calcium-dependent cell-cell adhesion of SKOV-3 cells resulted in a rapid increase of P-ERK, but did not modify the expression of ERK protein. The phosphorylation of ERK in the cells was blocked by pretreatment with the MEK1 specific inhibitor PD98059 (50 μmol/L), but not by the PI3K inhibitor wortmannin (1 μmol/L) or PKA inhibitor H89 (10 μmol/L).Conclusion:E-cadherin may function as a tumor proliferation enhancer via activating the MEK/ERK pathway in development of ovarian epithelial cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
Jiang, W. G., Sanders, A. J., Katoh, M., Ungefroren, H., Gieseler, F., Prince, M., Thompson, S. K., Zollo, M., Spano, D., Dhawan, P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.008 · Cited by 515
Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
Han, L., Li, Y., Tchao, J., Kaplan, A. D., Lin, B., Li, Y., Mich-Basso, J., Lis, A., Hassan, N., London, B., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu205 · Cited by 191
Self-citationXu, S., Yang, Y., Dong, L., Qiu, W., Yang, L., Wang, X., & Liu, L. (2014) · Scientific Reports · doi:10.1038/srep05646 · Cited by 50
Self-citationCiucci, A., Zannoni, G. F., Buttarelli, M., Martinelli, E., Mascilini, F., Petrillo, M., Ferrandina, G., Scambia, G., & Gallo, D. (2016) · Oncotarget · doi:10.18632/oncotarget.10797 · Cited by 27
“It is interesting to note, however, that mechanistic studies proved that in ovarian cancer cells, E-cadherin may serve not only as an intercellular adhesion molecule, but also as an upstream regulator that triggers downstream kinase activation, this explaining why E-cadherin is always expressed during ovarian tumor de…”
Background
Metadata
- Authors
- Dong, L.-L., Liu, L., Ma, C.-H., Li, J.-S., Du, C., XU, S., Han, L.-H., Li, L., & Wang, X.-W.
- Venue
- Acta Pharmacologica Sinica
- Published
- 2012-04-30
- Volume
- 33
- Issue
- 6
- Pages
- 817-822
- ISSN
- 0253-9756 (ISSN-L)
- 1671-4083
- 1745-7254
- OpenAlex
- W1995448152
- Cited by
- 48
- References
- 0
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway. https://app.cochat.ai/papers/10.1038/aps.2012.30
- The paper
- Dong, L.-L., Liu, L., Ma, C.-H., Li, J.-S., Du, C., XU, S., Han, L.-H., Li, L., & Wang, X.-W. (2012). E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway. Acta Pharmacologica Sinica. https://doi.org/10.1038/aps.2012.30
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.